Evidence map›Paper›PMID 18555774›Full record

ArticleCell2008

The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors.

Hiroshi Tsuda, Sung Min Han, Youfeng Yang, Chao Tong, Yong Qi Lin, Kriti Mohan, Claire Haueter, Anthony Zoghbi, Yadollah Harati, Justin Kwan and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 239 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. UtilizingJournal of developmental biology · 2025
    Review
  10. Article
  11. Article
  12. Molecular regulation of calcium-sensing receptor (CaSR)-mediated signaling.Chronic diseases and translational medicine · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Loss of Activity-Induced Mitochondrial ATP Production Underlies the Synaptic Defects in aThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Hiroshi TsudaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Sung Min Han
Youfeng Yang
Chao Tong
Yong Qi Lin
Kriti Mohan
Claire Haueter
Anthony Zoghbi
Yadollah Harati
Justin Kwan
Michael A Miller
Hugo J Bellen
Baylor College of Medicine · USHoward Hughes Medical Institute · USUniversity of Alabama at Birmingham · US

Funding

UNDERSTANDING FXTAS AMONG MALES WITH THE FMR1 PREMUTATIONP30HD024064 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI TOLIAS, KIMBERLY R · 1988 to 2013
$29.4M
Howard Hughes Medical InstituteNICHD NIH HHS P30 HD024064
6 · The paper itself

Abstract

VAP proteins (human VAPB/ALS8, Drosophila VAP33, and C. elegans VPR-1) are homologous proteins with an amino-terminal major sperm protein (MSP) domain and a transmembrane domain. The MSP domain is named for its similarity to the C. elegans MSP protein, a sperm-derived hormone that binds to the Eph receptor and induces oocyte maturation. A point mutation (P56S) in the MSP domain of human VAPB is associated with Amyotrophic lateral sclerosis (ALS), but the mechanisms underlying the pathogenesis are poorly understood. Here we show that the MSP domains of VAP proteins are cleaved and secreted ligands for Eph receptors. The P58S mutation in VAP33 leads to a failure to secrete the MSP domain as well as ubiquitination, accumulation of inclusions in the endoplasmic reticulum, and an unfolded protein response. We propose that VAP MSP domains are secreted and act as diffusible hormones for Eph receptors. This work provides insight into mechanisms that may impact the pathogenesis of ALS.

Indexed as

Amyotrophic Lateral SclerosisAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansCaenorhabditis elegans ProteinsCell LineDrosophila melanogasterDrosophila ProteinsEndoplasmic ReticulumHumansLigandsMembrane ProteinsProtein FoldingProtein Structure, TertiaryReceptors, Eph FamilyUbiquitinationCaenorhabditis elegans ProteinsDrosophila ProteinsLigandsMembrane ProteinsReceptors, Eph FamilyVAPB protein, humanVesicular Transport ProteinsVPR-1 protein, C elegans

Identifiers

PMID18555774
PMCPMC2494862
OpenAlexW2043921345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.